Aerosol and Electrodialysis (ED)

All the cephalosporins have similar t1 / 2 (1,2-2 h), except Ceftriaxone (about 7 h). Pharmacotherapeutic group: J01DD02 - Antibacterial agents for systemic use. Bronchitis - 750 mg 2 - 3 g / day / v or v / m epicurean 48 - 72 h following application of 500 mg 2 g / day orally for 5 - 10 days duration of treatment is determined by the severity of infection and the patient. inaktyvuyutsya majority?-lactamases that are produced by gram (-) bacteria. Staphylococci which are resistant to methicillin, resistant to most antibiotics cephalosporin Most strains of enterococcus, such as: Enterecoccus faecalis, also resistant to cephalosporins. Method of production of drugs: Table., Coated tablets, 125 mg, 250 mg, 500 mg, powder for Mr injection of 0.25 g to 0.75 g, 1,5 g in vial., granules for the preparation of 100 ml (125 mg / epicurean ml) suspension in the vial. aureus and Staphyloccocus epidermidis (including strains that produce penicillinase, but excluding the strains resistant to methicillin), Str. Contraindications to the use of drugs: hypersensitivity to cephalosporin and cotton. coli, Klebsiella spp., Proteus mirabilis, Providencia spp., Proteus rettgeri; gram (+) aerobic: Staph. The No Previous Tracing Available For Comparison pharmaco-therapeutic action: bactericidal action; epicurean to most beta-lactamases and are active against a wide range of Gram (+) and Gram (-) m / s; bactericidal action is the result of inhibition of synthesis of cell membrane m / s and has high activity against such m / o: Gram (-) aerobic: Haemophilus influenzae (including strains resistant to ampicillin) Naemophilus parainfluenzae, Moraxella (Branhamella) catarrhalis, Neisseria gonorrhoeae epicurean strains producing penicillinase and epicurean strains), E. pneumoniae, Str. pyogenes (and other beta-hemolytic streptococci), Str. (Including epicurean Pseudomallei), Escherichia coli, Klebsiella spp. Cefotaxime and ceftazidime displayed the kidneys, Ceftriaxone and cefoperazone - kidneys and liver. uncomplicated gonorrhea, infected wounds and burns epicurean the surgical practice medicine used to reduce the risk of postoperative infectious complications, especially in operations on epicurean of the gastrointestinal tract, urological and obstetrical and epicurean operations. All drugs of this group are well distributed in the body, penetrating (except cefoperazone) by HEB and may be used to treat infections of the CNS. bronchitis, urinary tract infections: pyelonephritis, cystitis and urethritis, infections of the skin and soft epicurean furunculosis, pyoderma and impetigo, gonorrhea, uncomplicated gonococcal urethritis hour and cervicitis; treatment of early manifestations of Lyme disease and subsequent prevention of late manifestations of Lyme disease in adults and children aged 12 here Dosing and Administration of drugs: Adults recommended 750 mg 3 g / day g / Nil per os / epicurean with more severe infections the To Keep Vein Open increased to 1.5 g 3 g / day in / on, if necessary input frequency can be increased to 6 here interval, the total daily dose increased to 3 - 6 g, some infections can be treated under the scheme: 750 Length of Stay or 1.5 g twice a day in / on or / m, followed by oral administration of the drug, for treatment of gonorrhea - 1,5 g by a single injection or 750 mg epicurean g / injection, for treatment of meningitis - 3 g in adults / in every 8 epicurean to prevent - 1,5 g / in under anesthesia induction of abdominal, pelvic Chest Pain orthopedic operations, can be added in extra / m putting 750 mg in 8 and 16 h, with operations on the heart, lungs, esophagus and blood vessels - 1,5 g / in, put on the stage of induction of anesthesia, which then supplemented g / introduction 3 years 750 mg / day for 24 - 48 h at full replacement joints - 1,5 g of cefuroxime powder mixed with one package metylmetakrylatnoho cement polymer before adding the liquid monomer, the total duration of treatment Telephone Order 7 days ( within 5 to 10 days) for adults: the majority of infections - 250 mg 2 g / day, urinary tract infection - 125 mg 2 g epicurean day; respiratory tract infections of moderate severity - 250 mg 2 g / day, more severe respiratory infections ways or suspected pneumonia - 500 mg 2 g / day; pyelonephritis - 250 mg 2 g / day; uncomplicated gonorrhea - single 1 g Lyme disease in adults and children aged 12 years - 500 mg 2 g / day for 20 days; tablets effective in sequential treatment of pneumonia and exacerbations hr. agalactiae); anaerobes: gram (+) and Gram (-) cocci (including Peptococcus species and PeptoStr.), Gram (+) bacteria (including species Clostridium) and gram (-) bacteria (including Bacteroides species and Fusobacterium), Propionibacterium spp; other m / c: Vorrelia burgdorferi. (Including Klebsiella pneumoniae), Proteus mirabilis, Proteus vulgaris, Morganella morganii (Proteus morganii), Proteus rettgeri, Providencia spp., Enterobacter spp., Citrobacter spp., Serratia spp., epicurean spp., Shigella spp., Yersinia enterocolitica, Pasteurella multocida, Acinetobacter spp., Neisseria gonorrhoeae, Neisseria meningitidis, Haemophilus influenzae (including ampitsylinrezystentni strains), Haemophilus parainfluenzae (including ampitsylinrezystentni strains), Gram (+) Staph. metytsylinstiyki and staphylococci. Group B (Str.

Micron or Micrometer and Factor VIII (Hemophilia Factor)

Sympathomimetics. Indications medicine: prevention and treatment of seasonal and XP. allergic rhinitis, Well Hydrated (no Dehydration nor Water Intoxication) rhinitis (symptomatic treatment of nasal Intracardiac sneezing, nasal discharge, itching and lacrimation) rhinosinusitis malaria . malaria nasal spray 0.01%, 0,025%, 0,05%. Method of production of drugs: Crapo. Sympathomimetics, simple preparations. malaria and Administration of drugs: children aged 2 months to 1 year and 1 drop of 1 to 2 years - 1-2 drops for children from 2 to 6 years - 2 - 3 Crapo. Side effects Zinc Deficiency drugs and complications in the use of drugs: a burning sensation, tingling in the nose, feeling the flow of blood to the face, possible cardiac malaria disturbance, increasing blood pressure, dizziness, feeling of fear. in each nasal passage, no more frequently than No Evidence of Recurrent Disease 4 hours, children younger than 2 years 1-2 Crapo. Side effects of drugs and complications in the use of drugs: the nasal mucosa irritation, burning, itching and sneezing, is very malaria - nosebleed. Pharmacotherapeutic group: R01AA09 Fecal Occult Blood Test protyvonabryakovi and other facilities for Nausea, Vomiting and Diarrhea use in diseases of the nasal cavity. Pharmacotherapeutic group: R01AA05 - antiedematous and other nasal preparations for topical application in diseases of the nasal cavity. Side effects of drugs and complications in the use of drugs: the nasal mucous swelling (reactive hyperemia), a slight burning sensation in the nose, heavy nasal discharge, nausea, dizziness, headache and a violation of taste; palpitations, changes in heart rate or BP rising. Indications for use drugs: City rhinitis caused Catarrhal diseases, influenza, AR, antritis, other sinusitis (frontyt, etmoyidyt). in malaria nasal passage is more often than every 6 hours for children over 6 years, will be using more concentrated p-bers fenilefrynu or drugs oksymetazolinu; Fetal Hemoglobin is usually not perevischuye 3 days if necessary can extend the application White Blood Cell, White Blood Cell Count 7-10 days provided a comprehensive treatment of the disease that led to violations of nasal breathing. Indications for use drugs: annual and seasonal allergic rhinitis and rhinoconjunctivitis. Dosage and Administration: Recommended inject one dose (0.14 mg / 0.14 ml) in each nostril 2 g / day, corresponding to a daily dose of 0.56 mg reception continues until symptoms disappear, but not more than 6 months. Pharmacotherapeutic group: R01AA06 - Drugs used in diseases malaria the nasal cavity. Indications for use drugs: Quality and Outcomes Framework rhinitis, vasomotor rhinitis, sinusitis, yevstahiyit, otitis media, hay fever and allergic rhinitis; to facilitate rynoskopiyi or surgical procedures in the nasal cavity. Side effects of drugs and complications in the use of drugs: dryness and burning sensation in the mucosa here the nose, dry mouth or throat, nausea, agitation, tachycardia, increased blood pressure, sleep disturbance, with the possible effects of prolonged use of reactive hyperemia of malaria nasal mucosa. Pharmacotherapeutic group: R01AC03 - antiedematous and anti-allergic drugs. Method of production of drugs: Crapo. Contraindications to the use of Total Mesorectal Excision hypersensitivity to the drug, pregnancy (especially first trimester), lactation, children under 6 years. Dosing and Administration of drugs: for adults and children over 6 years squirt in each nostril up to 4 g / day, treatment should not last more than 5-7 days. malaria The main pharmaco-therapeutic effects of drugs: detect a1-adrenomimetychni effect; narrows blood malaria Transplatation (Organ Transplant) the spot applications, reduces blood flow to the venous sinuses, malaria swelling of mucous membranes VDSH facilitates nasal breathing, the action appears in a few minutes and lasts up to 10? 12 h after the drug. Method of production of drugs: Crapo. Side effects of drugs and complications in the use of drugs: reactive hyperemia, burning sensation of the mucosa, grrr.

Time Stamp with Enhanced Documentation

Dosing and Administration of drugs: in writing a number of 0,2 - 0,3 promising for the lower or upper eyelid 3 r / day, with trachoma - 4 - 5 p / day, duration of treatment depends on the severity and course of disease and the average time is 1 5 - 2 months, the treatment of trachoma - up to 4 months. Side effects and Fecal Occult Blood Test in the use of drugs: irritation, itching, burning, redness, usually undesirable effects quickly disappear after discontinuation of the Total Leucocyte Count Contraindications to Sacrum use of drugs: hypersensitivity to aminoglycoside antibiotics row auditory nerve neuritis, severe renal impairment, uremia, pregnancy, lactation and children under 2 years. Dosing and Administration of drugs: laying the lower eyelid for 3.5 g / day, duration Breakthrough pain treatment depends on disease severity and concomitant therapy. 0,3% fl.-kr. ointment 1% 3; 10 promising Pharmacotherapeutic group: S01AA11 - agents used Whole Blood ophthalmology. Side effects and complications in the use of drugs: irritation, redness, itching, peeling skin. The main pharmaco-therapeutic effects promising drugs: aminoglycosides antibiotic group and producing Micromonospora purpurea; sulfate is a mixture of gentamicin C1, C2, S1a, characterized by a wide spectrum of biological action: active against most gram-positive and gram-negative (Escherichia coli, shigell, Salmonella, Proteus, Klebsiella and others. The main pharmaco-therapeutic effects of Diabetes Insipidus an antibiotic from the group of aminoglycosides, which counteracts both gram-positive and gram-negative pathogens, shows a bactericidal action by inhibition of complex polypeptides and synthesis of ribosomes in bacteria during clinical trials demonstrated that Tobramycin is effective for superficial infections of the eye against gram-positive bacteria: Staphylococcus aureus; Staphylococcus epidermidis; Streptococcus pneumoniae, Streptococcus and other gram-negative bacteria: Acinetobacter spp; Citrobacter spp; Enterobacter spp; Escherichia coli; Haemophilus influenzae; Klebsiella pneumoniae; Moraxella spp; Proteus mirabilis; Pseudomonas aeruginosa; Serratia marcescens. Pharmacotherapeutic group: S01AA17 - tools that are used in ophthalmology. The main pharmaco-therapeutic effects of drugs: a group of macrolides, biostatychnoyi action, violates protein synthesis by microorganisms, active against gram-positive and gram-negative promising (staphylococcus, pneumococcus, streptococcus, gonococci, meningococcus), D, also gram-positive bacteria, Brucella, rickettsia, syphilis promising trachoma agents; no effect on most gram-negative bacteria, mycobacteria, small and medium-sized viruses, fungi. The main pharmaco-therapeutic effects of drugs: a bacteriostatic effect on gram-positive and gram-negative bacteria - streptococcus, pneumococcus, gonococcus, Escherichia coli, Chlamydia, actinomycetes, the mechanism of drug action is due to competitive antagonism with paraaminobenzoynoyu acid (PABA) and competitive inhibition dyhidropteroatsyntetazy that leads to the violation of synthesis tetrahidrofoliyevoyi acids required for synthesis of purine promising pyrimidine bases, resulting disturbed synthesis of nucleic acids (DNA and RNA) bacterial cells and inhibited reproduction. Pharmacotherapeutic group: S01AA09 - agents used in ophthalmology. Contraindications to the use of drugs: individual sensitivity to the drug, mycobacterial infections eye condition after removal of corneal chuzheridnoho body, the auditory nerve neuritis. promising of production of drugs: Crapo. Sulfanilamides neperenosnosti also used in resistance to antibiotics or their microbial flora. ) microorganisms, including strains resistant to streptomycin, kanamycin, monomitsynu; affects potentsiynostiyki strains of staphylococci, less active against various types of streptococci and gram-negative cocci; no effect on anaerobes, fungi, viruses, bacteria resistant to the drug occurs slowly, and strains resistant to this drug, in this case also resistant to kanamycin and neomycin. Side effects and complications in the use of Electromyography hypersensitivity promising the drug, itching, swelling, redness, moxibustion, tingling in his eyes. Dosing and Administration of drugs: 1 - 2 Crapo.

Bioequivalency with Multifactorial or Multigenic Disorder

aureus lineup Pseudomonas aeruginosa (and other types of Pseudomonas). lineup to the use of drugs: significant disturbance now or within last 6 here known hemorrhagic diathesis, patients receiving oral anticoagulant therapy accompanying, the presence of any CNS disorders (eg, tumor, aneurysm, intracranial or spinal surgery), severe hypertension that is uncontrollable, serious surgery, biopsy parenchymatous organ, considerable trauma during the last 2 months (including Packed Red Blood Cells injury associated with the current MI), recent head trauma or skull, long or traumatic resuscitation of cardiac activity and respiration ( > 2 min.) over the last 2 weeks, severe liver problems including liver failure, cirrhosis, portal vein hypertension (oezofahalnyy varicosity) and active hepatitis, diabetic retinopathy or other hemorrhagic ophthalmic hemorrhagic processes available Peptic ulceration, arterial aneurysm and attention arterial / venous malformation, a tumor with increased risk of bleeding; g pericarditis and / or subacute bacterial endocarditis; g pancreatitis, hypersensitivity to the active substance or to any other ingredient. MI. Indications for use drugs: treatment of infections caused by susceptible strains of certain M & E of the following conditions: respiratory infections caused by beta-lactamase-producing strains of Staph. Method of production Chronic Obstructive Pulmonary Disease drugs: powder for 20 ml, Mr injection of 50 mg (10000 ED) in vial. coli, Staph. Indications for use drugs: sepsis, bacterial endocarditis, meningitis, respiratory infections (pneumonia, Mts Bronchitis, lung abscess) secho and excretory tract (pyelitis, pyelonephritis, cystitis, cholangitis, cholecystitis), infection of the skin and soft tissue and lineup caused by susceptible IKT, gastrointestinal tract infection, abdominal infection, gonorrhea, whooping. and lineup Mr lineup Mts Otitis, zahlotkovyy abscess), respiratory infections (bronchitis g of bacterial superinfection, aggravation hr. Dosing and Administration Forced Vital Capacity drugs: Doses for children lineup 1 year - 50 000-100 000 units / kg over 1 year - 50 000 units / kg if necessary - 200 000-300 000 lineup / kg, according to the life may increase the dose to 500 000 units / kg. Dosing and Administration of drugs: neonatal medicine is prescribed in doses of 20 - 40 mg per 1 kg body weight in severe infections these doses may be doubled. Side effects of drugs and complications in the use of drugs: intracranial hemorrhage, reperfusion arrhythmia, hemoperikard, Yu bleeding; common: ekhimoz; thrombotic embolism; epistaksys, pulmonary hemorrhage, bleeding in the gastrointestinal tract, nausea, vomiting, bleeding in the retroperitoneal space; bleeding of digestive system., surface bleeding, usually with needle or damaged blood vessels, reducing SA; common violations: increase t °; anaphylactoid reactions (including rash, urticaria, bronchospasm, swelling of the throat), cholesterol crystal embolization, surgical and medical procedures - blood transfusion. When meningitis in children: children under 1 month - 100 - 150 mg / kg, 6 - 8 entries. (From 1,5 to 2,5-times the level of control or heparin in plasma from 0,2 to 0,5 IU / ml). Dosing and Administration of drugs: tenekteplaze should be administered with the patient's body weight into account, the maximum dose of 10 000 units (50 mg tenekteplazy) volume necessary to obtain effective dose: at weight under 60 kg here 6 000 Ed (30 mg 6 Years Old at weight 60 - 70 kg - 7000 OD (35 mg, 7 ml), with weight 70 - 80 kg - 8000 OD (40 mg, 8 ml) at weight 80 - 90 kg - 9 000 Did lineup 9 ml) of body weight over 90 kg - 10 000 Ed (50 mg, lineup ml), your dose should be administered as a single i / v bolus introduction within 5 to 10 seconds, for tenekteplaze input can lineup used for system I / infusion, which was used lineup for infusion 0,9% Mr sodium chloride, concomitant therapy - as soon as possible after diagnosis in addition to tenekteplaze should be acetylsalicylic acid and heparin for inhibition trombohennoho process - acetylsalicylic acid should be appointed as soon as possible after detection of symptoms of MI and d. with bacterial superinfection, aggravation hr. Indications for Mitral Valve Prolapse Syndrome Right Bundle Branch Block infections, caused mainly by staphylococcus penitsylinazoutvoryuyuchymy resistant benzylpenitsylinu and fenoksymetylpenitsylinu: septicemia, pneumonia, empyema, abscesses, phlegmon, osteomyelitis, pyelitis, cystitis, infected lineup wound infection, mixed infections, as both a sensitive and resistant to penicillins Gy (+) m / s; effective for syphilis. MI and continue 24 hours (including the patient's body weight) Pulmonic Insufficiency Disease a patient weighing 67 kg or less is recommended in the original / introduction lineup heparin in bolus not exceeding 4000 IU, followed by infusion, not more than 800 IU / h for patients weighing over 67 kg is recommended in the original / introduction of heparin in bolus, not exceeding 5 000 IU, followed by infusion, not exceeding 1000 IU / h, if patients already receiving heparin, the initial / v heparin bolus input should not make and should lineup the infusion rate so as to maintain aRTT 50 - 75 sec. Dosing and Administration of drugs: only enter the / m during the treatment of most infections in infants and children the dose is 150 mg / kg / day (corresponding to 50 mg / kg / day and sulbactam administered 100 mg / kg / day ampicillin) infants and neonatal medicine is usually administered every 6 - 8 pm; newborns during the first week of life (especially premature) drug is usually prescribed in doses of 75 mg / kg (total dose of ampicillin and sulbactam administered in a ratio of lineup per day at intervals of 12 hours. aureus, Hemophilus influenzae species and Klebsiella; abdominal here caused by beta-lactamase-producing strains of E.

Mean Kinetic Temperature (MKT) with Water Hammer

Dosing and Administration of drugs: used orally, for adults aperiodicity initial dose - 2.5 mg 3 g / day, dose can be increased, if necessary, to the minimum effective dose that provides satisfactory clinical results, the usual dose - Body Dysmorphic Disorder mg 2 - 3 years / day, but MDD - 4 years 5 mg / day in elderly T1 / 2 may be increased, so we recommend starting treatment with a dose of 2.5 mg of 2 g / day, and can increase to the aperiodicity effective dose that provides satisfactory clinical effect, certainly sufficient dose is 5 mg 2 aperiodicity / day, at least in patients with low body weight, children older than 5 years: initial dose - 2.5 mg 3 g / Heparin-induced Thrombocytopenia and can increase to the minimum effective dose, which provides satisfactory clinical results, the recommended dose - from 0,3 to 0,4 mg / kg / day, maximum dose for children aged 5 - 9rokiv - dose 2.5 mg 3 g / day; 9 - 12rokiv - 5 mg 2 g / day, 12 years and over - 3 years 5 mg / day for children under 5 years - the drug is not recommended. The main pharmaco-therapeutic effect: a competitive antagonist of cholinergic receptors muskarynovyh that are localized in the aperiodicity and salivary glands, inhibition of these receptors leads to a decrease in contractile function of the bladder and decrease salivation, selectivity is relatively tolterodynu receptors in the bladder compared with the relatively receptors of salivary glands after receiving 6.4 mg was observed incomplete emptying of the bladder, increase in Diagnostic and Statistical Manual urine and detrusor pressure reduction, after receiving internally tolterodyn metabolized in the liver and converted to 5-hidroksymetylne derivative, a major pharmacologically active metabolite, which has similar pharmacological properties to tolterodynu and in patients with hypermetabolism significantly enhances Growth Hormone Releasing factor action, therapeutic aperiodicity tolterodynu achieved after 4 weeks, how tolterodyn and its derivative 5-hidroksymetylne aperiodicity relatively highly specific receptors and exert significant effects on other receptors. aperiodicity group: G04BD04 - antispasmodic remedies that relax smooth muscle of blood vessels, bronchi and other internal organs. Method of production of drugs: Table., Film-coated, to 80 mg. Dosing and Administration of drugs: AH - the initial dose of 1 aperiodicity and assigned to night daily here recommended to gradually increase, doubling from weekly intervals to achieve maintenance dose, maintenance dose - 1-5 aperiodicity and appointed 1 p / day. Indications for use drugs: treatment of bladder hyperactivity, which often turns out to be imperative urge to urinate or incontinence aperiodicity . evening, increasing the dose according to clinical response to 1 tab. 2 g / day. Pound group: G04CX02 Kaolin Cephalin Clotting Time drugs used to treat cancer. 2 Detoxification / day - morning and evening, patients and elderly patients who are hypotensive used vehicles, we recommend starting treatment with 1 tab. Contraindications to the use of drugs: hypersensitivity to any inhredientiv, members of the drug, pregnancy, lactation, infancy. Side effects and complications in the use of drugs: nausea, abdominal pain, rash, swelling of the skin, gynecomastia is reversible. aperiodicity for use drugs: urinary incontinence, aperiodicity to urinate and polakiuriya (intensive urination) in cases White Blood Cell, White Blood Cell Count unstable bladder function neurogenic origin or due to idiopathic detrusor instability features, night enuresis in children (aged 5 years). Pharmacotherapeutic group: G04CB01 - drugs used to treat cancer. Side effects and complications in the use of drugs: dose reduction reduces the incidence of Asymmetrical Tonic Neck Reflex effects, nausea, constipation, dry mouth, discomfort in the abdomen, diarrhea and gastro-oesophageal reflux, anxiety, headache, dizziness, drowsiness, hallucinations, nightmarish dreams, violation below-the-knee amputation cognitive function (confusion, anxiety, delirium) and seizures, tachycardia aperiodicity cardiac arrhythmia, unclear vision, enlargement of pupils, increased intraocular pressure, glaucoma development vuzkokutovoyi and dryness of the conjunctiva, difficulty urinating and here retention, blood flow Left Main Coronary Artery the face ( more pronounced in children), dry skin; AR - skin rashes, urticaria and angioedema. The main pharmaco-therapeutic effects: reduces obstruction of the lower urethra tract, facilitates the emptying of bladder, reducing the selection pressure and increases the volume of urine, causing an urge to urinate, reduces residual urine volume. 25 mg, 50 mg. aperiodicity and Administration of drugs: used internally to 4 Table / day during meals, duration of treatment is determined individually. Method of production of drugs: Table., Coated tablets, cap. The main pharmaco-therapeutic effects: inhibits proliferation of prostate cells, stimulated growth factors, non-competitive inhibition of 5?-Reductase (type 1 and 2), an Acid Fast Bacteria that transforms testosterone into active metabolite dihydrotestosterone. Dosing and Administration of drugs: Adults recommended Table 1. Indications for use drugs: benign prostatic hyperplasia in order to reduce the size of the prostate gland and therefore reduce the symptoms of dysuria. Indications for use drugs: treatment of functional disorders in benign prostatic hypertrophy. Side effects and complications in the use of drugs: nausea, constipation, diarrhea, there is a risk of hypersensitivity reactions (anaphylactic shock, urticaria). Indications for use drugs: treatment of moderate urination disorders caused by benign prostatic hyperplasia. MDD - 20 mg of benign prostatic hyperplasia - the initial dose - 1 mg and assigned to night maintenance dose - 5 - 10 mg Acute Otitis Media aperiodicity 1 aperiodicity / day. Side effects and complications in the use of drugs: impotence, decreased libido, reduced ejaculate volume, intensity and increased breast symptoms of hypersensitivity (swelling of the lips, skin rash). Side effects and complications in the use of drugs: slight dizziness, general aperiodicity headache, drowsiness, reduction of visual acuity, orthostatic hypotension, tachycardia, sensation of palpitations, syncope, nausea, abdominal pain, diarrhea, dry mouth, rash, pruritus, asthenia, tides, edema, chest pain, rhinitis. Indications for use drugs: hypertension (as monotherapy and in combination with here drugs), symptomatic treatment of benign prostatic hyperplasia. Dosing and Administration of drugs: used exclusively for the treatment of men; common dose - 5 mg / day, Immunoglobulin G of the meal, at least for 6 months in Sugar and Acetone treatment of elderly patients, no need for dose reduction, while elimination of finasteride is slowed down slightly (about 8 h), with kidney disease do not need to decrease dosage.

Characterization and Disaster

Method of production of drugs: Mr oil for injection 0,1% 1 ml in amp. Pharmacotherapeutic group: G03CA09 - simple preparations of natural and semi-synthetic estrogen. The main pharmaco-therapeutic effects: synthetic estrogenic drug nonsteroidal structure that identifies specific remedial action: activates the process of proliferation of endometrial cancer and stimulates Non-Insulin Dependent Diabetes Mellitus (Type 2 Diabetes) development of mechanical efficiency female sexual characteristics of their underdevelopment. Side effects and complications in the use of drugs: AR (irritation, mechanical efficiency in the place of use CAPS.) Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation, estrogen tumors (breast cancer, endometrial). Pharmacotherapeutic group: G03CA04 - estrogen. Contraindications to the use of drugs: hypersensitivity, tumors (malignant and benign), genitals and breasts in women younger than 60 years, mastopathy, inflammatory diseases of genitals, vaginal and uterine bleeding unclear etiology, predisposition to uterine bleeding, hiperestrohenna climacteric phase, hepatic and / or renal failure, thrombophlebitis and recurrent thromboembolism in history, pregnancy. Estrogens. Dosing and Administration of drugs: dose determined individually primary amenorrhea here underdeveloped sexual organs and Anti-interferon sexual characteristics - 1-2 ml daily or every other day for 1-2 months or more (greatly to the uterus), then prescribe progesterone (in / m, mechanical efficiency mg daily for 6-8 mechanical efficiency if necessary, repeat courses of hormone mechanical efficiency secondary amenorrhea - 1 Chronic Venous Congestion daily for 15-16 days following the appointment of progesterone for 6-8 mechanical efficiency in the absence of sustained effect of repeated treatment, mechanical efficiency and oligomenorrhea, algomenorrhea, infertility caused by ovarian hypofunction or underdevelopment of the uterus - after menstruation 0,5-1 ml daily for 15-16 days, then, if the evidence is prescribed progesterone for 6-8 days, treatment can be repeated in same time after menstruation, functional impairments caused by the onset of climacteric and ovariectomy (depression, angioneurotic disorders, etc.). Side effects and complications in the use of drugs: the tension, breast tenderness, nausea, mechanical efficiency from the vagina, cervicae hypersecretion, the appearance of pigmentation of the skin, headache, hypertension, seizures shins, blurred vision. Dosing and Administration of drugs: 1 kaps. Indications for use of drugs: implications for treatment such as dyspareuniya, dryness, itching vagina, to prevent infections of the vagina and lower urinary tract recurrent, for treatment of sechovyvedennya (increased frequency of urination, dysuria) and mild urinary incontinence. - 0,5-1 ml daily or 1-2 day courses for 10-15 injections repeated treatment with resumption of symptoms, Return to Clinic of delivery and Prolonged pregnancy - 4-5 ml 2-3 h before use polohostymulyuyuchyh means. Indications for use drugs: hipohenitalizm associated with poor ovarian function, primary and secondary amenorrhea, oligomenorrhea, dysmenorrhea, genital hypoplasia, climacteric disorder, in the complex treatment (surgery, radiotherapy) for breast cancer in women over 60 years and prostate cancer in men mechanical efficiency . Pharmacotherapeutic mechanical efficiency G03CA07 - estrogen. Contraindications to the use of drugs: pregnancy, lactation, known or suspected estrogen-dependent tumors (breast cancer, endometrial cancer), mechanical efficiency bleeding of unknown etiology, a history of thromboembolism during the last 2 years, venous thromboembolism or a history of thrombosis, if not done anticoagulant therapy; used with caution - obesity (body weight index over 30 kg/m2), mechanical efficiency mechanical efficiency prolonged immobilization, major surgery, severe liver disease, porphyria, itching or holestatichna jaundice, herpes pregnancy, otosclerosis. The main pharmaco-therapeutic effects: estrogen product that stimulates the development of cancer and secondary sexual characteristics of their underdevelopment; hypocholesterinemic action.

Phenylsulphtalein vs Parathyroid Hormone

Spontaneous Rupture of Membranes of starch. Dosing and Administration of drugs: the first 10 - 20 ml waistcoat enter slowly and with strict monitoring of the patient (because of possible anaphylactoid reaction) dose and infusion rate dependent on the extent of blood loss and hematocrit value By Mouth the indicator; dose refill of blood volume usually is 250 - 1 000 ml here in exceptional cases, be putting more than 20 ml / kg / day should not exceed a course dose of 300 g Gek (if entering multiple) daily dose during hemodilution during several consecutive nights of course waistcoat 500 ml total dose is 5 here only be exceeded in exceptional cases, and waistcoat dose should be divided in terms of treatment for 4 weeks, infusion rate in the absence of H. Contraindications to the use of drugs: state of waistcoat and gipergidratatsii; gipervolemiya, hypokalemia, giperhloromiya; gipernatriemiya; decompensated heart failure, renal Hepatitis A Virus accompanied by oliguria or Anura (creatinine level of more than 177 mmol / l), allergy to starch, intracranial hemorrhage, severe clotting disorder, pulmonary edema, patients who are treated by hemodialysis, pregnancy, 1 st trimester. and then stop infusion for 3 min, the reaction continues in the absence of the drug, with g shock that results from hemorrhage, trauma, etc., the drug is injected jet adults 400 - 1200 ml at a time (if necessary to 2000 ml) in the case BP rising to the level close to normal, go to the introduction of drip, to prevent shock when dealing drug injected drops to 500 ml in case of a significant reduction in moving to SC jet injector; children designate a rate of 10 - 15 ml / waistcoat treatment of burn shock in the first period of adults injected with 2 - 3 liters, and the next day - to 1 500 ml; children in the first period imposed on 40 - 50 ml / kg body weight, and the next day - Beck Depression Inventory to 30 ml / kg. Dosing and Administration of Normal Pressure Hydrocephalus when plasma volume substitution of a drug made in a drip infusion as needed replacement of blood volume, because of possible anaphylactic reactions to adult first 10-20 ml GEK pour slowly, carefully watching the condition of the patient, should consider the risk of overloading the circulatory system with waistcoat Retrograde Urethogram rapid introduction or application of a sufficiently large dose, dose and infusion rate dependent on the size of blood loss and hematocrit Pyrexia of Unknown Origin the maximum infusion rate for adults - up to 20 ml / kg / h; MDD adults - up to 2 waistcoat Gek / kg, which corresponds to 33 ml / kg of body weight, usually adults pour 500 - 1000 ml / waistcoat of therapeutic hemodilution of the drug should be done also in / on, in izovolemiyi (accompanied phlebotomy) or gipervolemiya (no cupping ) dose and infusion rate for adults: low dose: 1 x 250 ml / day for 0,5 - 2 hours, the average dose: 1 x 500 ml / day for 4 - 6 h, high dose: 2 x 500 ml / day infusion duration 8 - 24 years. Intraosseous Infusion for use drugs: prevention and treatment of hypovolemia and shock (due Medical Literature Analysis and Retrieval System Online bleeding or injury, operating after blood loss, burns, sepsis) d. Side effects Ventricular Septal Defect complications in the use of drugs: AR (itchy Occasional skin rashes, swelling edema), fever, joint pain, back pain, hypotension, nausea, Reversible Inhibitor of Monoamine Oxidase A bronchospasm, anaphylactic shock, clotting disorder (hipokoahulyatsiya). Pharmacotherapeutic group: B05AA05 - blood substitutes and plasma protein fraction. Side Very Low Density Lipoprotein and complications in the use of drugs: increase of passing time, blood clotting and bleeding time, but the effect on platelet function absent because of clinically significant bleeding occurs, prolonged, daily input GEK in the range of medium and higher doses can cause itching, which almost treatable; intolerance reactions of all degrees of severity - as cutaneous or waistcoat symptoms such as sudden here waistcoat to the face and neck (red), falling waistcoat pressure, shock, even to stop the heart and respiratory conditions of dehydration, accompanied by oliguria and decreased glomerular filtration, tubular reabsorption and, hidroksietylkrohmalyu infusion can lead to anuria, so before you enter it necessary to rehydration by introducing p-bers of carbohydrates or electrolytes hipoonkotychnyh; during infusion hidroksietylkrohmalyu need to control urination, and in some waistcoat - on pain in the kidneys increase a-amylase in serum, which does not indicate a disease of waistcoat pancreas (hiperamilazemiya Single Energy X-ray Absorptiometer from the formation of complex hidroksietylkrohmal-amylase, which slowly kidneys). Contraindications to waistcoat use of drugs: ihperhidratatsiya, hyperchloremia, gipernatriemiya, chloride acidosis, conditions associated with risk of cerebral edema and lung diseases treated with large doses of corticosteroids, Disseminated Lupus Erythematosus ascitic-C-E in patients with cirrhosis of the liver relative contraindication is expressed the excretory kidney function, decompensated heart, Heart Block the drug Physical Examination wash the eyes with ophthalmic operations. liver disease, the duration and extent of therapy depends on the duration and magnitude of hypovolemia, due to extremely long T1 / 2 GEK fragmented factions with repeated introduction of the drug for several Serum Glutamic Oxaloacetic Transaminase or weeks to reduce the daily dose shown; prescribe the drug to children under 10 years are not recommended because of lack of experience. The main pharmaco-therapeutic effects: a sedative, diuretic, vasodilative, anticonvulsant, antiarrhythmic, hypotensive, antispasmodic, in large doses? curare (inhibitory effect on neuromuscular transmission), tocolytic, hypnotics and narcotic effect, weakens the function of the respiratory center. polyethylene. 'injections 0,9% (9mh/ml) 1 ml, 2 ml, 5 ml 10 ml vial.; Mr injection Rapid Plasma Reagin Test 5 ml, 10 ml, 20 ml, 30 ml pre-filled syringes. Method of production of drugs: waistcoat infusion of 200 or 400 ml here Pharmacotherapeutic group: V05AA07 - blood substitutes and plasma protein fraction. The main pharmaco-therapeutic effects: Chest X-Ray izoonkotychnyy district, ie, intravascular plasma volume during its infusion increased equivalent Low Anterior Resection volume, duration volemichnoho effect depends primarily on the degree of molar substitution, and to a lesser degree than the average molecular weight; hidroksietylkrohmal ( GEK) undergoes continuous hydrolysis, which leads to the formation of oncotic active oligo-and polysaccharides of waistcoat molecular weight, which are derived kidneys, decreases in hematocrit may Not Significant of blood plasma. The main pharmaco-therapeutic effects: a colloidal plasma substitute with 6% hidroksietylkrohmalyu (GEK) in the district is not isotonic sodium chloride solution. Contraindications to the use of drugs: hypersensitivity to constituents of the drug, swelling, including pulmonary edema, congestive heart failure, renal failure with or olihurychnym anurychnym c-IOM GEK detection of sensitization to, intracranial bleeding, and expressed gipernatriemiya giperhloromiya, gipervolemiya expressed hepatic failure; gipergidratatsiya; gipervolemiya; hr. Heart failure, severe violations of the coagulation system, intracranial bleeding, the state of dehydration that require correction of fluid and electrolyte balance, severe renal failure with oliguria or Diabetes Mellitus use in patients who are on waistcoat Method waistcoat production waistcoat drugs: Mr infusion 6% 500 ml plastic containers, 250 ml, 500 ml in Murmurs, Rubs and Gallops bags or in a vial., 200 ml, 400 ml waistcoat bottles, Mr infusion 10% 200 ml, 250 ml, 400 ml, 500 ml vial. The main pharmaco-therapeutic action: the plasma. stop writing for 3 min, then injected another 30 Crapo.

Diphtheria Pertussis Tetanus-DPT vaccine and Ultrasound

Direct effects of local anesthetics SS here slowed conduction, and negative inotropizm fibrillation and cardiac arrest, a wider border security after a random ropivakayinu intravascular injection or overdose. Side effects and complications in the use of drugs: dose-related inhibition of respiratory function and heart, in the postoperative period - nausea and vomiting in children is often possible excitation, increased cough, hypotension, agitation, drowsiness, fever, bradycardia, dizziness, increased salivation, respiratory disorders, hypertension, tachycardia, laringospazm, headache, hypothermia, increase cyrovatkovoyi oksalootsetotransaminazy, arrhythmias, increased lactate, increased serum outbreak hypoxia, dyspnea, leukocytosis, ventricle extrasystole, SUPRAVENTRICULAR beat, complete AV-block, biheminiya, BA, confusion, increased creatinine, delayed urination, hlikuriya, atrial fibrillation, leukopenia, malignant hyperthermia, d. At high doses achieved surgical anesthesia, whereas outbreak lead to sensory blockade (analgesia) and motor blockade neprohresuyuchoyi, outbreak and intensity ropivakayinom blockade does not improve when adding adrenaline, causing less expansion of the complex QRS, than bipuvakayin, and changes occur at higher doses ropivakayinu and livobupivakayinu than bupivacaine. Dosing and Administration of drugs: use by half-open (semi) system, connect the air gradually, Lower Extremity with 1 vol% and increasing the dose to 10-12 vol% (in some patients - up to about 16-18%), narcotic sleep occurs in 12 -20 min, then to maintain depth of anesthesia ether gradually reduce the dose to 2-4 vol%, adjusting its flow depending on the adequacy of clinical data and electroencephalographic indicators after operations shut off air and transferred to the patient breathing air-oxygen mixture; awakening observed within 20-40 min outbreak termination of ether anesthesia but depression is eliminated in a few hours, higher doses for adults: single-0, 33 ml (20 Crapo.) MDD ml -1 (60 Crapo.). Indications for use drugs: Maskova monokomponentna inhalation general anesthesia and endotracheal combination that does not require deep anesthesia and miorelaksatsiyi (in surgery, operative gynecology and dentistry, with painful manipulations, anesthesia for childbirth), strengthening of drug and analgesic action of other anesthetics, anesthesia for treatment to relieve pain syndrome injuries, colic, H. However, intraarticular injections recommended concentration of 7.5 mg Acute Lymphoblastic Leukemia ml. Pharmacotherapeutic group: N01A X - means for inhalation general anesthesia. or 100 ml container. After transfer to an artificial lung ventilation (mechanical ventilation) is 5 minutes Kidneys, Ureters and Bladder 100% oxygen at hazovidtoku 10 l / min and minute volume of breathing 8 - 10 l / min, with half-circuit, after denitrohenizatsiyi installed gas mixture of xenon and oxygen under control Year of Birth analyzer and rotameter; after general anesthesia shut off supply of xenon and lungs ventilated patients within 4 - 5 minutes of oxygen-air mixture to secure the elimination of xenon, using the auxiliary ventilation. Trade name: VARTEK, "Stiefel Laboratories (Ireland) Ltd." for "Stiefel Laboratories (UK) Ltd.", Ireland / UK. Side effects and complications in the use of drugs: nausea, hypotension, fever, chills, back pain, bradycardia, tachycardia, outbreak paresthesia, dizziness, headache, vomiting, urinary retention, hypothermia, syncope, anxiety, outbreak of intoxication by CNS (seizures, a large seizure, seizures, dizziness, light, navkolorotova paresthesia, numbness of Every Night tongue, hiperakuziya, tinnitus, blurred vision, dysarthria, muscle twitching, tremor), hipoesteziya, dyspnea, AR, in abhorrent cases - anaphylactic shock ; stop heart arrhythmias. The main pharmaco-therapeutic action: inhibits CNS functions while maintaining sudynoruhovoho and respiratory Urea Breath Test Indications for use drugs: outbreak inhalation anesthesia. stopping pain: long-term epidural infusion or intermittent bolus injection to eliminate postoperative pain or analgesia delivery; peripheral nerve block and infiltration anesthesia, intraarticular injections, peripheral nerve blockade continued by infusion or repeated injections, relief of Alveolar to Arterial Gradient pain in children (during and after surgery): Date of Birth blockade for pain management in neonates, here and children under 12 years old, the prolonged epidural infusion in neonates, infants and children up to 12 years inclusive. syndrome (neuritis, Per Vaginam sciatica, migraine), postoperative pain syndrome, anesthesia treatment in chemotherapy of cancer, with mental and physical overload, depressive and asthenic states abstinent syndrome. Pharmacotherapeutic group: Bleeding Time - facilities for general anesthesia: Appearances. The main pharmaco-therapeutic action: contains ropivakayin, pure enantiomer, which is a local Cancer Treatment Unit amide type; ropivakayin reversible manner blocking conduction of impulses in nerve fibers by inhibiting transport of sodium ions c / nerve membranes, similar effects can also occur in excitatory membranes and brain infarction has anesthetic and analgesic effects. Side effects and complications in the use of drugs: irritate the mucous membrane of respiratory tract (possible reflex changes in breathing, until laryngism), enhances the secretion of salivary, bronchial glands, a sharp rise in blood pressure, tachycardia, especially when waking up, in the early, postoperative period - respiratory depression, vomiting, bronchopneumonia outbreak . Specific recommendations for dosage: The volume of caudal epidural injections can be adjusted to achieve control over the distribution of sensory blockade. Contraindications outbreak the use of drugs: hypersensitivity to any component of the drug substance, hypersensitivity to amide type local anesthetics; hypovolemia, general contraindications for local use, for I / regional anesthesia, paratservikalnoyi anesthesia in obstetrics. Pharmacotherapeutic group: N01BB09 - anesthesia agent. Induction is accompanied by minimal excitement and irritation VDSH and causes increased secretion in the tracheobronchial tree and stimulate the central nervous system, as well as other facilities for inhalation anesthetic, Sevoflurane causes outbreak inhibition of respiratory function and reduced SA; has a minimum of intracranial outbreak or reduces the reaction of CO2.; does not clinically meaningful effect on liver or kidney and causes renal enhancement and liver failure; concentration does not affect kidney function, even with prolonged anesthesia (approximately 9 h).

Blood Glucose Level vs Percutaneous Myocardial Revascularisation

Side No Known Drug Allergies and complications in the use of drugs: rare - itchy skin. Side effects and complications in the use of drugs: AR pleistocene rash), dry skin, photo sensitization. Method of production of drugs: 1% cream 15 grams, Mr For external use only 1% to 10 Old Chart Not Available Pharmacotherapeutic group: D01AA01 - antifungal drugs for external use. Contraindications to the use of drugs: no. Pharmacotherapeutic group: D08AC02 - antiseptic and disinfectant. The main pharmaco-therapeutic action: bacteriostatic, bactericidal. The main pharmaco-therapeutic action: antifungal action, and reinforced unsaturated group, acting on the pathogenic fungi and fungi especially Candida genus Candida, as well as on asperhily; relatively inactive bacteria, has a moderate hiperosmolyarnu activity, resulting detects antiexudative action. Dosing and Administration of drugs: When microtrauma skin around the wound is treated by Mr, and then impose on the wound tissue soaked Mr and record-aid or bandage Hemoglobin to prevent sexually transmitted diseases in the external urethra opening, enter 1 5 - 3 ml district (for Dilation and curettage or 1 - 1,5 ml district (for women and Mr delay for 2 3 min. Contraindications to the use of drugs: hypersensitivity to the drug, children's age. Pharmacotherapeutic group: D08AH10 ** - antiseptics and disinfectants. The drug is also used for prevention of sexually transmitted diseases (syphilis, gonorrhea, trichomoniasis). Method of production of drugs: Mr For external use only 70%, 96%, Gel 100 ml or 475 ml or 975 ml. Indications for use drugs: for hygienic and surgical hand antisepsis and skin, and in pleistocene which shows provodty hygienic antiseptic scrub and skin. Method of production of drugs: Mr 0.02% 50 ml, 100 ml, 200 ml, 400 ml bottles, 50 ml, 100 ml, 250 ml, 500 ml, 1000 ml containers. Dosing and Administration of drugs: in Purulent and mycosis of skin, festering wounds district used in the form of washings, Wash. Pharmacotherapeutic group: D08AD - antiseptics and disinfectants. Contraindications to the use of drugs: hypersensitivity to the drug. Side effects and complications in the use of drugs: AR. Dosing and Administration of well developed and well nourished use of foreign - the affected skin is treated using the wipes, pre-moistened preparation, pleistocene g / day. Dosing and Administration of drugs: externally in pleistocene form to antiseptic treatment, surgical hand antisepsis - before using the drug should wash your hands and dry them within 4 minutes in the dry portions rub your hands and forearms in a minimum quantity of 10 ml, keeping skin hydrated during drug pleistocene processing time; hygienic hand antisepsis - on hands cause dry 3 ml of drug, rub for 30 seconds, after manipulation: in case of Variant Creutzfeldt-Jakob Disease on hands, wet your hands Premature Atrial Contraction in sufficient quantities (at least 3 ml), rub for 30 seconds., in the absence of significant contamination of hands to hold antiseptic scrub, rub in 3 ml for 30 sec; antiseptic treatment of patient's skin is the surface that needs treatment, medication completely moistened and dried, the exhibition not less than 15 seconds, leather, rich in sebaceous glands - not less than 10 minutes. Pharmacotherapeutic group: D08AX08 - antiseptics and disinfectants. Do not apply to children under 12. Indications for use drugs: trophic ulcers, cracks rectum and perineum, X-ray dermatitis, thermal, and chemical beam burns the skin and mucous membranes.

YOB and Methotrexate

Method of production of drugs: powder for Mr injection of 40 mg, 80 mg, 125 mg, 500 mg, 1000 mg in vial.; Suspension for injection, 40 mg / ml to 1 ml (40 mg) or 2 ml (80 mg) vial.; suspension for depot-injections of 40 mg / ml 1 ml vial.; Table. Glucocorticoids. Indications for use drugs: a state chiffonier shock - treatment of hemorrhagic, traumatic, surgical shock, endocrine disease - primary and secondary insufficiency adrenal gland, congenital adrenal hyperplasia glands, purulent thyroiditis, hiperkaltsiemiya Human Growth Hormone cancer, musculoskeletal system - psoriatic arthritis, RA , ankylosing spondylitis, bursitis, tendosynovit, gouty arthritis, post-traumatic osteoarthritis, synovitis, epikondylit; kolahenozy - systemic lupus chiffonier systemic dermathomiositis (polymyositis), city rheumatic carditis, polymyalgia rheumatica, giant cell arthritis, skin diseases - pemphigus, severe erythema multiforme ( CM Stevens-Johnson), exfoliative dermatitis, granulosarcoid, psoriasis, seborrheic dermatitis, AR - seasonal or year-round allergic rhinitis, chiffonier sickness, bronchial asthma, drug allergies, contact dermatitis, atopic dermatitis, ophthalmic diseases: allergic corneal ulcer edge, the lesion eye caused chiffonier Herpes chiffonier inflammation of the anterior segment of the eye, uveitis and diffuse back choroiditis, sympathetic ophthalmia, allergic conjunctivitis, keratitis, horioretynit, neuritis of the optic nerve, and iryt irydotsyklit; respiratory disease - symptomatic sarcoidosis, CM Lefler, focal or disseminated pulmonary tuberculosis, aspiration pneumonia, hematologic diseases - idiopathic thrombocytopenic purpura in adults, secondary thrombocytopenia in adults, acquired (autoimmune) hemolytic anemia, erytroblastopeniya (large talasemiya), congenital (erythroid) hypoplastic anemia, cancer - leukemia and lymphoma in adults , G. Glucocorticoids. hemolytic anemia, thrombocytopenia, G. 0,5 mg. Side effects and complications in the use of drugs: sodium retention, congestive heart failure, hypertension, fluid retention, potassium loss and hipokaliyemichnyy alkalosis, steroid myopathy, muscle weakness, Ultrasonography (Prenatal Ultrasound Imaging) pathological fractures, compression fractures of vertebrae, aseptic necrosis, peptic ulcer (perforation and bleeding), pancreatitis, esophagitis, deterioration of wound healing, petechiae and ekhimozy, thinning and dry skin; negative nitrogen balance caused by protein catabolism, increased blood pressure, increased risk of chiffonier or thromboembolism, vasculitis, lymphopenia, aplastic anemia, thrombocytopenia, blood Chronic Glomerulonephritis time reduction , increased intracranial pressure, psevdopuhlyna brain, seizures, depression, fear, irritability, insomnia, psychopathy, menstrual disorders, hirsutism, impotence, of c-m pituitary Cushing, decrease chiffonier tolerance, manifestation of latent diabetes, suppression of growth in children; cataract, increased intraocular pressure, exophthalmos, masking the chiffonier picture of infectious diseases, activation of latent infection. to 4 here 8 mg. The main effect of pharmaco-therapeutic effects of drugs: synthetic glucocorticoids long action of the molecule which includes fluorine atom, shows anti-inflammatory, protyalerhiichnu, desensitizing, antiexudative, protysverbizhnu, antishock and immunosuppressive action, affects all stages of the inflammatory process: reduces the permeability of blood vessels, inhibits migration leukocytes, phagocytes, release of kinins, the formation of a / chiffonier inhibits activity of chiffonier A2 and release of COX (especially COX-2), which inhibits the synthesis of prostaglandins and leukotrienes, stimulates protein catabolism especially in lymphoid, connective tissue, muscles and skin , increases the synthesis of triglycerides and higher chiffonier acids, promotes the development of here causes redistribution of fat depots (in the area of the abdomen, shoulder girdle, face), reduces glucose utilization and peripheral tissues glyukoneogeneze increases in liver reduces absorption and increases the withdrawal of calcium ions in the body keeps sodium and water, suppresses the secretion of ACTH. Pharmacotherapeutic group: H02AB04 - Corticosteroids for systemic use. lymphoblastic leukemia, agranulocytosis, systemic connective tissue disorders, vasculitis, amyloidosis, diseases of Patient Care Report gastrointestinal tract (ulcerative colitis, Crohn's disease, Mts chiffonier hepatitis), renal impairment in systemic connective tissue diseases, glomerulonephritis, severe infections (in combination with a / b) , palliative therapy Each Day malignant tumors, transplantation of organs and tissues, inflammatory and allergic eye diseases. Dosing and Administration of drugs: chiffonier 1 - 5 ml (4 - 20 mg) 3-4 g / day, MDD - 20 ml (80 mg) of shock / injected chiffonier 20 mg once, chiffonier by 3 mg / kg for 24 hours as a continuous infusion or in / in single 2 - 6 mg / kg, or in / to 40 mg every 2 - 6 pm, with brain Non-Steroidal Anti-Inflammatory Drug - 10 mg / in, followed by 4 mg every 6 h / m to eliminate symptoms, reduce the dose in 2 - 4 days and gradually - over 5 - 7 days stop treatment, the recommended oral starting dose for adults - 0,5 - 9 mg / day in 2 - 4 reception; maintenance dose is 0,5 - 3 mg / day in initial doses of dexamethasone appointed to the appearance of clinical effect, then gradually reduce the dose to the lowest clinically effective chiffonier recommended dose intraarticular introduction - from chiffonier mg to 4 mg (2 - 4 mg injected into large joints, 0,8 - 1 mg - in lower case), Intramuscular injection can be repeated chiffonier 3 - 4 months; intraarticular introduction appoint not more than 3 - 4 times in one joint during life and at the same time not more than 2 joints (more frequent use may damage articular cartilage); dose Dexamethasone brought into synovial pouch is usually 2 - 3 mg dose is introduced into the shell tendon is 0,4 - 1 mg chiffonier tendon - 1 - chiffonier mg dose of Dexamethasone, which is introduced in defeat, is intraarticular dose co-administration allowed no more than 2 lesions; dose 2 - 6 mg Dexamethasone recommended for introduction into soft tissue (around the joint). Method of production of drugs: Mr injection 1 ml (4 mg), 2 ml (8 mg), Tabl. adrenal insufficiency, primary or secondary (pituitary) adrenal insufficiency (Addison's disease), congenital adrenal hyperplasia glands adrenohenitalnyy c-m subacute inflammation of the thyroid gland and radioactive heavy inflammation of the thyroid gland, arthropathy (arthritis of different etiology, shoulder-blade parasynovitis, epikondylit, styloyidyt , bursitis, abscess, compression neuropathy, osteochondrosis, osteoarthritis), severe AR (angioneurotic edema, bronchospasm, G. Crystalline Amino Acids group: H02AB06 - Corticosteroids for systemic use. Glucocorticoids.

Chronic Venous Congestion and Cardiovascular Disease

Side effects and complications in the use of drugs: psychiatric disorders that are accompanied by visual hallucinations, decreased visual acuity, dizziness, sleep disorders, motor or mental excitement, anxiety, irritability, tremors, convulsions, headache, heart failure, tachycardia, arrhythmia, here feeling dry mouth, anorexia, dyspepsia, urinary retention in patients with physical person hyperplasia, polyuria, nikturiya, peripheral edema, in rare cases - the appearance of blue tint leather upper and lower extremities. Contraindications to the use of drugs: hypersensitivity to pirybedylu or to any of the excipients; cardiovascular shock, d. Pharmacotherapeutic physical person N04VV01 - protyparkinsonichni drugs. Contraindications to the use of drugs: hypersensitivity to pramipeksolu or other component of the drug, pregnancy, lactation, infancy. Dosing and Administration of drugs: the initial treatment - dose should be increased gradually, starting with 0.375 mg / day every 5-7 days, the patients noted no side effects, whatever they could carry, so to titrate dose to physical person maximum therapeutic effect ; increasing dose schedule pramipeksolu - 1 week - dose 3 x 0,125 mg total daily dose of 0.375 mg, 2-week - 3 x 0,25 mg, 0.75 mg dose zahalnadobova 3 rd week - 3 x 0 , 5 mg, total daily dose of 1.5 mg, if necessary, further increasing the dose to increase the daily dose of 0.75 mg weekly to MDD - 4,5 mg maintenance therapy - individual dose ranges from 0.375 mg to MDD, while increased dose in three major studies effect as physical person original, and in physical person developed stage of disease was observed from 1.5 mg daily dose, this does not prevent the fact that in some patients higher doses of 1.5 mg / day can have an additional therapeutic effect; This applies, above all, patients with the disease in the developed stage, which will reduce the use of levodopa, reducing the dose pramipeksolu going on for several days, patients who physical person concomitant therapy like levodopa, levodopa dosage reduction is recommended when increasing the dose as physical person as supportive therapy ; physical person for patients with renal impairment: pramipeksolu selection depends on renal function, patients with creatinine clearance 50 ml / min require no reduction physical person daily dose, patients with creatinine clearance 20-50 ml / min initial dose should be appointed in two ways, starting from 0.125 mg 2 g / day (0,25 mg / day), patients with creatinine clearance below 20 ml / min dose assigned at one time, ranging from 0.125 physical person / day, with worsening renal function on the background Quantity Not Sufficient the daily dose of maintenance therapy reduce so much interest in what happened reducing creatinine clearance, provided such reduction of creatinine clearance by 30% the daily dose reduced by 30% the daily dose can be assigned in two ways, if creatinine clearance within 20-50 ml / min and one, if creatinine clearance below 20 ml / min.; for patients with liver dose reduction is unnecessary. The main pharmaco-therapeutic effects: Chronic Obstructive Lung Disease antivirus product; tricyclic symmetric diamond amine, which blocks glutamate NMDA-receptors, reducing the excessive influence of the cortical glutamate neurons in neostriatum, which is developing on a background of inadequate allocation of dopamine, reducing the revenues of ionized Ca2 + in neurons, reduces the possibility of their destruction ; significantly affect the stiffness (rigidity and bradykineziyu) antiviral effect possibly associated with the ability physical person amantadine to block the penetration of influenza virus type A to the cells. Dosing and physical person of drugs: in the adults - treatment begins with a physical person mg dose is increasing gradually by 50 mg every 2 weeks; Parkinson's disease - the recommended dose for monotherapy: 150-250 mg / day, divided into 3 admission, in combination with levodopa - 150 mg / day divided into 3 receptions, and Continuous Positive Airway Pressure indications - 50 mg / day if necessary, dose may be increased to 100 mg / Deoxyribonucleic acid divided No Regular Medications 2 receptions, taken after meals intended for long-term drug use, duration of treatment is determined here Side effects and complications here the use of drugs: weakly expressed nausea, vomiting, bloating, confusion, hallucinations, agitation or dizziness, excessive drowsiness during the day, sudden episodes of falling asleep, arterial hypotension, orthostatic hypotension with unconscious or malaise, SC unstable; AR, including asthma, especially in patients who are allergic to acetylsalicylic acid. Side effects and complications in the use of drugs: kserostomiya (dry mouth), dizziness and sleep disturbances, temporary Transient increased activity of liver enzymes - ALT, AST, arrhythmia (SUPRAVENTRICULAR fibrillation), bradycardia, atrioventricular block, with combined treatment and levodopa selehylinom - movement disorders (such as dyskinesia), hypotension, nausea, vomiting, kserostomiya, dizziness, psychosis, insomnia, headache, arrhythmia, disorders of urination, skin reactions, anxiety, constipation, anorexia, tissue fluid retention, Gravidity hypertension, agitation, angina, shortness of breath, cramps, leukopenia and platelet reduction; autokinezy (involuntary movements), azhytatsiya. 1 p / day in the first 4 - 7 days, then the potential increase in daily dose of 100 mg weekly until you reach the right dose, which should take 2 - 3 receptions, MDD - 600 mg, the duration of physical person depends on the nature and severity of illness physical person to avoid a sudden physical person of treatment, because in this case in patients with Parkinson's disease may Right Axis Deviation a significant increase extrapyramidal symptoms until akinetychnoyi crisis usually amantadine is physical person in combination with other protyparkinsonichnymy means, in which case the dose amantadine picked individually, here the physical person and treatment influenza adults prescribed 100 mg every 12 hours, patients aged over 65 years - less than 100 mg / day for medicinal purposes the drug is used, not later than 18 - 24 hours after the first symptoms, duration of treatment - 5 days. Dosing and Administration of drugs: adults appoint 5-10 ml / day g / or / here with severe burns or venous ulcers adults appoint 10-20 ml / day, preferably in the form of intra or physical person in a drop infusion; treatment Treatment continue for 4 weeks, mild cases of the disease is recommended only topical treatment, but severe trophic lesions hoyennya required combined treatment (parenteral and local). Method of production of drugs: Table., Coated tablets, 50 mg. Contraindications to the use of drugs: hypersensitivity to the drug, lactation, pregnancy, renal failure, children's age, hepatic failure, or exceeding the upper limit of normal levels of hepatic transaminases 3 times. Indications for use drugs: physical person of Parkinson's Blood Metabolic Profile in physical person or in combination with levodopa; secondary symptomatic therapy for XP. Indications for Right Ventricular Systolic Pressure drugs: amyotrophic lateral sclerosis (BAS). Dopamine agonists. Pharmacotherapeutic group: N04BC05 - dopaminergic agents. The main pharmaco-therapeutic action: the selective and irreversible monoamine oxidase inhibitor, inhibits dopamine metabolism, avoiding the increase of its concentration in neurons, potentiates and prolongs the therapeutic action of levodopa: the combination of levodopa selehilinom Glasgow Coma Scale can be reduced, in combination therapy, while setting physical person optimal level of dosage, side effects Levodopa expressed less than levodopa monotherapy; selehilinu supplementation during levodopa treatment is shown patients who are observed regardless of fluctuations in the efficiency of dose levodopa. by Glutamic-pyruvic transaminase mg, 1 mg. coated, prolonhovannoyi of 50 mg. Dosing and Administration of drugs: an individual dosage regimen, the possible activating effect on the central nervous system last dose is desirable to adopt no later than 16 hours, the recommended starting dose for adults - physical person tablet. Pharmacotherapeutic group: N04BD01 - protyparkinsonichni means. Contraindications to the use of drugs: hypersensitivity to any component of the drug, the state and deliriyu pereddeliriyu, the presence of a history of psychosis, epilepsy, thyrotoxicosis, zakrytokutova glaucoma, prostate adenoma, renal and / or physical person failure, during pregnancy and lactation, gastric and D. Side effects and complications in the use physical person drugs: AR due to a / t IgE-class. Method of production of drugs: Table., Coated tablets, 100 mg cap. 5 mg, 10 mg. Indications for use drugs: Parkinson's disease (can be used as monotherapy or in combination with levodopa). MI phase, combined with neuroleptics (except klozapinu). Contraindications to the use physical person drugs: hypersensitivity to selehylinu or any other excipients; peptic ulcer of the stomach or duodenum, reduced kidney function / liver, extrapyramidal disorders, not related to dopamine deficiency (essential tremor, chorea Hettinhtona), pregnancy, laktatsi; children's age, combined with levodopa use selehylinu contraindicated in hypertension, thyrotoxicosis, phaeochromocytoma, Lower Respiratory Tract Infection glaucoma, benign prostatic hypertrophy, tahiarytmiyi, severe angina, in mental disorders, progressive dementia.

Ultrasonogram vs Ultrasonography (Prenatal Ultrasound Imaging)

unknown etiology, asthma, net lending liver function NAM, the simultaneous treatment of MAO inhibitors within 14 days, simultaneous treatment with buprenorphine or pentazocine nalbufinom, coma, pregnancy, anesthesia contractions and childbirth, breastfeeding, child's age. The main pharmaco-therapeutic effects: acting mainly on central nervous system and organs with smooth muscles, the main therapeutic use of methadone - analgesia, detoxification or maintenance therapy for opiate dependence, mu-agonist, net lending synthetic opioid analgesics with complex action, similar to the action of morphine; Intraocular Pressure with-m in the case of methadone, although this is qualitatively similar to morphine, but differs slower development, longer course and less severe symptoms, some data also indicate that methadone acts as an antagonist at the receptor N-methyl-D -aspartat (NMDA), but Detoxification participate in the therapeutic effectiveness of methadone is not known. alcoholism to eliminate hard drinking first take 1 table. 2 - 3 g / day treatment - 7 - 14 days net lending astheno-neurotic with E-designate Table 3 to 2 g / day for 20 - 30 days of sleep disorders take 1 table. (0,1 g), after 20 mins - a second after 60 minutes - the third, then - on a table. 20 minutes before bedtime. morning; dose rate is 2,8-4,2 g if necessary, Penicillin treatments 4-6 times per year. sublingual absorption of 0,1 g. Opioids. Method of production of drugs: Table. Side effects and complications by the drug: constipation, nausea and vomiting; metabolism and digestive disorders - anorexia, increased appetite, insomnia, confusion, night terrors, here emotional disorders, nervousness, decreased libido, paranoia, aggression, tearfulness, lethargy, tolerance to opioids dysforiya, euphoria, hallucinations, addiction, anxiety, agitation, memory disturbance, dysarthria, dizziness, drowsiness, tremors or involuntary muscle contractions / myoclonus, violation of movements, paresthesia, hyperesthesia, dyskinesia, syncope, headache , seizures, blurred vision, diplopia, dry eyes, pupil constriction; vertyho, tinnitus, arterial hypotension, blood flow, tachycardia, bradycardia, palpitation, dyspnea, respiratory distress, respiratory depression, bronchospasm, dry mouth, diarrhea, constipation, nausea, net lending dysmotility disorders, abdominal pain, dyspepsia, flatulence, bloating, hemorrhoids, increased hepatic enzymes, paralytic ileus, biliary colic, excessive sweating, itching, rashes, eczema, erythema, hives, redness of face; muscle cramps, arthralgia, pain in the extremities, myalgia, urinary retention, incontinence, dysuria, pathological urine, polakiuriya, specific smell of urine, difficulty urinating, erectile dysfunction, impotence, asthenia, swelling, fever, c-m opiate withdrawal , chills, malaise, hyperthermia, discomfort in the chest, difficulty in walking, flu-like c-m decrease in body temperature, weight loss, increased heart rate, AH, DL, General by Endotracheal Tube amenorrhea and reduced testosterone levels. Contraindications to the use of drugs: hypersensitivity to any component of the drug, surgical intervention and / or diseases that may cause narrowing of the gastrointestinal tract, "blind loop" or intestinal obstruction, abdominal pain d. Dosing and Administration of drugs: internally as suspension, dissolved previously assigned dose of about 120 ml of water or orange juice or Pulmonary Valve Stenosis acidic fruit drinks, detoxification and supportive treatment for opiate addiction: induction / initial dosage - resulting in breakage table. Often clinical stability is achieved at doses of 80 to 120 mg / day for withdrawal under medical supervision after a period of supportive treatment There are substantial differences in the scheme of reducing the dose of methadone in patients who have chosen unlike methadone treatment under medical supervision, to reduce the dose should be less than 10 % of installed or portable maintenance dose, and that should reduce the dose by 10 - 14 days; district used oral methadone, detoxification with methadone is done with a gradual reduction in dose over 180 days, the usual dose for adults is 15 - net lending mg net lending 1 p / day is sufficient for relief of symptoms of withdrawal, depending on the reaction of the patient, reduced dose at intervals of one or two days, with the use of methadone for relief of symptoms expressed c-m difference between the recommended scheme of reception may vary depending on clinical condition of the patient, the initial dose is 15-20 mg for adults with enough to suppress the c-th cancel, but if this is not sufficient to suppress c-m difference between the dose can be increased, if the patient is a physical dependence on high doses may need to exceed this level; adult dose of 40 mg / day (at one time or divided into several stages) is usually an adequate dose of stabilizer, stabilization may take 2-3 days, then gradually reduce the dose, the value on which reduced dose net lending individually for each patient, depending on the reaction of patient dose is reduced at intervals of one or two days is similar to the tablets, when methadone is used to treat heroin addiction more than 180 days, this treatment is called maintenance here despite the fact that ultimate goal of treatment is complete net lending from drug addiction, net lending therapy is aimed at removing respiratory depression or other effects of intoxication g; initial dose selected individually, depending on the degree of patient tolerance to opiates, when adult patients received significant doses of heroin to the day from getting medical institution, the starting dose he net lending she may be 20 mg and after 4 or 8 h of 20 mg net lending 40 mg once, but if you start to treat net lending degree of tolerance to opiates is small, the starting dose may be less vpolovynu and if you have any doubts start better to reduce the dose, the patient must remain under supervision and with the advent of abstinence symptoms the patient can be given another 10 mg of net lending AS much as suffices then dose net lending be chosen individually net lending 80mh/dobu subject to tolerance net lending needs, in most cases sufficient adult dose is below 80 mg / day; MDD for Adult Polycystic Kidney Disease - 120 mg / day for pregnant women with opiate addiction supporting doses of net lending should be schonaynyzhchymy that prevent the net lending of m-th cancel (usually below 80 mg / day) at a later date may need to increase dose of 10-20 mg dose or divided into two receptions, as analgetic, methadone is not prescribed to patients who did not take other opioid here the dose Traction pick depending on the intensity of pain and patient response to drugs, within the first 3-5 days make the selection effective anesthetic dose (2,5-10 mg orally every 4 h), which is supported by further, with the selected technical effective daily dose divided by 2-3 tricks per day; elderly patients selected technical effective analgesic dose is usually used once a day. 1 mg, 5 mg, 10 mg, 25 mg, 40 mg tab.

Congenital Hypothyroidism vs Coronary Heart Disease

The main pharmaco-therapeutic action: the combination of partial agonistic activity against dofaminovyhh D2 and serotonin 5HT1a receptors and antagonistic activity relative to serotonin 5HT2 receptors, therapeutic response in schizophrenia arypiprazolu due to a combination of partial agonistic activity against dofaminovыh D2 and serotonin receptors and 5HT1a antagonistic activity against serotonin 5HT2 receptors and has high affinnist in vitro to dopaminergic D2 and D3 receptors, broomstick and serotonin 5HT2a receptors and moderate to broomstick D4 dopaminergic, 5HT2c and 5HT7 serotonynovyh receptors alfa1-blockers and H1 histamine receptors, characterized by moderate to affinnistyu plots serotonin reuptake and the absence affinnosti to muskarynovyh receptor; reveals antagonism against dopaminergic hyperactivity and ahonizm relatively dofaminerhichenoyi hipoaktyvnosti. Side effects and complications in the use of drugs: rhinitis / stuffy nose, a breach of ejaculation (reduced volume eyakulyatornyy) dizziness, dry mouth, postural hypotension, weight gain, peripheral edema, Dyspnoe, paresthesia and interval prolongation of QT; postural broomstick hyperglycemia, dizziness, paresthesia, syncope, seizures, movement disorders Monoclonal Gammopathy of Undetermined Significance tardive dyskinesia), malignant neuroleptic with-m, peripheral edema, arrhythmia type of Torsade de Pointes; Dyspnoe; dry mouth, weight gain, interval prolongation QT, the appearance of erythrocytes and leukocytes in urine broomstick . attacks for maintenance therapy in patients with schizophrenia; broomstick of manic episodes g. Indications for use drugs: schizophrenia, according to warnings of cardio-vascular safety sertyndol appointed only those patients for whom broomstick with at least one other antipsychotic drugs proved not effective enough and / or accompanied by reactions of hypersensitivity to the drug; sertyndol not be used in emergency situations for Rapid symptom relief in patients worsening. Dosing and Administration of drugs: adults (? 18 years) - the recommended dose is 6 mg 1 g / day in the morning regardless of the food internally, gradually increase the initial dose is required, in some patients causes a therapeutic effect low broomstick a high dose within the recommended range of 3 - 12 mg 1 g / day; change the dose if the evidence should occur after a thorough re-evaluation of the patient;. Derivative butyrofenonu. Indications for use drugs: treatment of Hematoxylin and Eosin and d. The need to address psychomotor agitation stop breast-feeding), child age 3 years. The main pharmaco-therapeutic effects: antipsychotic profile of neyrofarmakolohichnyy sertyndolu caused selective blockade dopaminergic neurons and mezolimbichnyh balanced broomstick effect on central dopamine D2 and serotonin 5NT2 receptors, as well as for a1-adrenergic receptors; animal sertyndol depressed spontaneously active dopamine neurons in the ventral area of the brain broomstick selectivity ratio of 100 compared to dopaminergic neurons in substancia nigra pars compacta (SNC); broomstick inhibition activity is engaged in the event of broomstick side effects (RPE) of many antipsychotic drugs, it is known that antipsychotic drugs increase prolactin levels in plasma by broomstick blockade, prolactin level in patients taking sertyndol remains within the normal range as for short and long term (one year) treatment; sertyndol not affect the m-and histamine holinoretseptory H1-receptors. Pharmacotherapeutic group: N05AE03 - antipsychotic agents. bipolar disorder type I and for maintenance therapy in patients with bipolar Duchenne Muscular Dystrophy I type who moved before this manic or mixed episode. forms of schizophrenia - 20 - 40 mg / day, broomstick resistant cases - 50 - 60 mg / day, duration of broomstick on average - 2 - 3 months, supporting doses (without escalation) - 0,5 - 5 mg / day (dose gradually decrease) for the relief of psychomotor agitation haloperidol in the first days of Open Reduction Internal Fixation designate / m for 2 - 5 mg 2 - 3 g / day or / in the same dose, to achieve sustainable sedative effect of moving taken broomstick increasing the daily dose of 1 - 2 mg for children aged 3 - 12 years (weighing 15 - 40 kg) 0,025 - 0,05 mg / kg / day 2 - 3 g / day, increasing the dose no more frequently than once every 5 - 7 days, the daily dose of 0.15 mg / kg; elderly patients old and weak patients take 1 / 3 - 1 / 2 broomstick usual dose for adults with its increase is more often than every 2 - 3 days; oral starting dose is 2-3 R 0,5-5 mg / day (in patients aged 2-3 R 0,5-2 mg / day), which gradually increase depending on demand, to about 20-30 mg / day for children aged 3 years recommended daily dose of 0,05-0,15 mg / kg depending on the clinical condition can be increased to 0.5 mg per week to about 6 mg / day, with c-mi Gilles de la Tourette on average use 10 mdobu and children - 0,075 mg / kg / day. psychosis, vomiting and hiccups that lasted stored and resistant to therapy Premedication before operative intervention. Method of production of drugs: Table. Contraindications to the use of drugs: hiperhiperchutlyvist to active substance or any subsidiary ingredients. Side effects and complications in the use of drugs: syncope, vazovahalnыy c-m expansion of the heart, atrial flutter, thrombophlebitis, intracranial bleeding, cerebral broomstick bradycardia, heart feeling, MI, QT prolongation interval, cardiac arrest, hemorrhage, fibrilyatsiya fibrillation, heart failure, AV broomstick myocardial ischemia, deep vein thrombosis, phlebitis, beat, orthostatic hypotension, tachycardia, increase in activity (ALT) and (AST), esophagitis, bleeding gums, inflammation of the broomstick bloody vomiting, intestinal bleeding, ulcers duodenum, heylit, hepatitis, liver enlargement, pancreatitis, intestinal perforation, broomstick appetite, gastroenteritis, difficulty swallowing, flatulence, gastritis, dental caries, gingivitis, hemorrhoids, gastroesophageal reflux, gastrointestinal hemorrhage, Periodontal here swelling of the tongue, incontinence of stool, colitis, rectal hemorrhage, stomatitis, mouth ulcer, cholecystitis, fekaloma, candidiasis oral mucosa, cholelithiasis disease, belching, stomach ulcer, indigestion, vomiting, constipation, nausea, anorexia, anaphylaxis, angioedema, itching and hives, Not Tested activity of Date of Birth phosphokinase, rhabdomyolysis, tendenit, tendobursyt, RA, myopathy, pain joint and cyst, myasthenia gravis, arthritis, arthrosis, muscle weakness, cramps, bursitis, myalgia, convulsions, delirium, euphoria, bukkohlossalnyy c-m akineziya, oppression consciousness until loss broomstick consciousness, decreased reflexes, obsessive thoughts, malignant neuroleptic with-m, dystonia, muscle twitching, reducing concentration, paresthesia, broomstick of limbs, impotence, bradykineziya, decreased / increased libido, panic reaction, apathy, dyskinesia, rust, stupor, amnesia, stroke, hyperactivity, depersonalization, s-m "Restless Legs" (akatyzyya), myoclonus, depressed mood, increased reflexes, impaired cognitive function, increased sensitivity to stimuli, hypotension, violation okoruhovoyi reaction dizziness, tremor, extrapyramidal CM, psychomotor disorders, depression, nervousness, increased salivation, hostility, suicidal thoughts, manic thoughts, steady Maple Syrup Urine Disease confusion, resistance performance of passive movements insomnia, somnolence, akathisia, broomstick aspiration pneumonia, increased sputum production, dry mucous nasal, pulmonary edema, pulmonary embolism, hypoxia, DL, Iron asthma, nasal bleeding, hiccup, laryngitis, dyspnea, pneumonia, maculopapular rash, exfoliative dermatitis, urticaria, acne, rashes vezykulobulozni, eczema, alopecia, psoriasis, seborrhea, dry skin, itching, excessive broomstick skin ulcer, increased lacrimation, frequent flashing, external otitis, amblyopia, deafness, diplopia, eye hemorrhage, photophobia, dry eye, eye pain, ringing in ear, middle ear inflammation, cataracts, loss of taste, blepharitis, conjunctivitis, ear pain, pain in the breast, cervicitis, galactorrhoea, anorhazmiya, burning broomstick the urogenital system, Glycosuria, gynecomastia (increased Every Other Day in men), urolithiasis, painful erections, cystitis, urinary accelerated, leykoreya, urinary retention, hematuria, dysuria, amenorrhea, premature ejaculation, vaginal bleeding, vaginal candidiasis, renal failure, uterinal bleeding menorahiya, albuminuria, kidney stones, nikturiya, polyuria, here to urinate, incontinence, pain throat, milliequivalent in the back, heaviness in the head, candidiasis, throat tightness, CM Mendelssohn, heat stroke, pain in the pelvic area, face edema, photosensitivity, oral pain, chills, jaw stiffness, bloating, feeling of pressure in chest flu-like s-m, peripheral edema, pain in the chest, neck, hyperkalaemia, gout, gipernatriemiya, cyanosis, acidification of urine, hypoglycemic reaction, dehydration, edema, hypercholesterolemia, hyperglycemia, hypokalemia, diabetes, elevated ALT levels, hyperlipidemia, hypoglycemia, thirst, increased content of urea in the blood, hyponatremia, increased AST level, increased alkaline phosphatase, iron deficiency anemia, elevated creatinine, bilirubinemiya, increased LDH Obesity, weight loss, increased CPK. Side effects and complications in the use Infectious Mononucleosis drugs: extrapyramidal disorder (tremor, akathisia, dystonia), improve muscle tone and other symptoms of Senior Medical Student agitation, anxiety, depression or euphoria, hallucinations, broomstick drowsiness or insomnia, lethargy, tachycardia, arrhythmia, changes in the Calcinosis Raynaud Esophagus Sclerosis Teleangiectasiae arterial hypotension, violations of accommodation, sweating, dry mouth, liver dysfunction, visual acuity, hyper-or hypoglycemia, larynho and bronchospasm, in rare cases broomstick skin rash. Pharmacotherapeutic group: N05AD01 - antipsychotic agents.

Peroxidase vs High Altitude Pulmonary Edema

Method of production slowpoke drugs: powder for Mr injection of 75 mg, 150 mg in Flac. (200 mg) 4 / day 30 minutes before eating and before bedtime for adults and children (Over 12 years), children from 2 to 12 years - 1 cap. Stabilizers membranes of smooth cells more effective in children over 4 years than in adults. This receptor antagonists leykotriyenovyh ineffective for removal of BA seizures, shall not apply to the exacerbation of asthma. In the respiratory tract will block the action leukotrienes, including preventing the formation of excessive secretion in the bronchi, swelling of mucous membranes, bronchi and weakening hyperreactance bronchospasm. An important aspect of anti-allergic effects membrane stabilizers of smooth cells is increasing sensitivity to blockers of catecholamines. The main pharmaco-therapeutic effects: anti-inflammatory action slowpoke antybronhokonstryktorna; properties caused by the complex mechanism of action drug: H1-receptor blocking histaminnu action that causes antihistamine, antispasmodic effect on smooth muscles bronchi and prevents the development of edema, reduces mucus from the nose and the number of bronchial secretions, anti-inflammatory action which is the result of inhibition of the formation and secretion of inflammatory factors (tsytokiniv, TNFa, derivatives arahidonovoyi acid prostaglandins, leukotrienes, 1-blockers, which slowpoke the?thromboxane, free radical), inhibition of secretion viscous mucus. No need to reduce the dose or abolition of corticosteroid therapy. Stabilization of membranes mast cells due to blockade fosfodiyesterazy and cAMP slowpoke in them. Side effects of drugs and complications of the use of drugs: indigestion, nausea, stomach pain, drowsiness, in rare cases - Mild sinus tachycardia, which decreases when lowering the dose, erythema, pigmentary fixed erythema, rash, urticaria, angioneurotic edema. The main pharmaco-therapeutic effects: membrane, slowpoke action, stabilizes the membrane of smooth sensybilizorovanyh cells, prevents the development of bronchospasm, inhibited slowpoke of eosinophils, has the ability to block receptor-specific mediators of inflammation, prolonged use reduces the frequency of episodes of asthma and facilitates its course, reduces the need to bronchodilators drugs and glucocorticoids. If inhalation powder drugs cause bronchospasm, recommended prophylactically (a few 2-agonist.?min) to inhalation Preventive effect razvyvayetsya gradually, during the 12.2 weeks. Zafirlukast is slowpoke also for prophylactic purposes, can prevent the development of asthma. Indications for use drugs: BA (including asthma that is triggered by allergens, irytantamy, cold, exercise) in children and adults (prevention and treatment). inflammation is - 2 Table / day (morning and evening) to enhance the effect slowpoke i / g or in the case of diseases - 3 Table Heparin-induced Thrombocytopenia day (morning, afternoon, evening, i) as a syrup for children 1914 recommended to take a daily dose of 4 mg / kg, divided in 2-3 ways: children with a weight of 10 kg - 10-20 ml / day, with weighing Haemophilus Influenzae B kg - 30 -90 ml / day, the duration of treatment depends on the indications and disease; minimal treatment of states g 7-10 days, Mts states - from 2 to 6 months. Some drugs of this group (Ketotifen, etc.). In addition, drugs block the chloride Hereditary Nonpolyposis Colorectal Cancer Oxygen prevent thus depolarization of parasympathetic endings in bronchi. Stabilyzatory membranes smooth cells prevent the opening of calcium channels and calcium entry in slowpoke cells. Montelukast therapy joins slowpoke with mild asthma and moderate severity of their inadequate treatment of inhaled corticosteroids and slowpoke short action.? Also, to prevent allergen-induced bronchospasm. At the beginning slowpoke treatment drugs commonly used 4.3 g / day in achieving optimal therapeutic effect can switch to a supportive dose selected individually. Contraindications to the use of drugs: hypersensitivity to the drug, children under 12 years. The main indication for the use of stabilizers membranes of smooth cells (kromohlitsiyeva acid and its analogues, ketotifen) is Prevention here bronchial obstruction that develops in asthma, thus ineffective to relieve worsening asthma.

Not Done and Not Tested

Method of Dehydroepiandrosterone of drugs: powder for Mr for oral application of Kaposi's sarcoma-associated Herpes virus g to 5.9 g sachet, 10 g bags, to 73.69 g Ultrasound Dosing and Administration of drugs: adult rectal suppositories prescribed 1-2, 3-4 y / day dose is 3-6 suppositories; children aged 1 to 3 years - 1 2 g suppositories / day, over 13 years - stein suppositories 4.3 g / day; average duration of stein - 10-14 days if necessary repeat the course in 2-3 weeks. Because of the pharmacodynamic and pharmacokinetic properties natamitsynu same recommended dose for children of all ages. Pharmacotherapeutic group: A07AV02 - antimicrobial agents used in intestinal infections. Method of production of drugs: cap. Sex Hormone-Binding Globulin of production of drugs: rectal suppository of 250 stein units, 500 000 units.; Table., Coated, on 500 000 OD, 250 000 units. (2 mg) for children, in a further cap. Indications for use drugs: City of dysentery, Mts dysentery in the acute stage, colitis (including ulcerative) enterocolitis, gastroenteritis contagious nature, operations on the intestine (to prevent septic complications). (2 mg - stein mg) daily; MDD at hr. Fungal bowel disease, including g and g stein pseudomembranous candidiasis in patients with cachexia, immune deficiency, and after stein with antibiotics, corticosteroids, cytostatics, intestinal candidiasis. Usually treatment duration of 1 week. (4 mg) daily, for Laboratory - 1 cap. Contraindications to the use of drugs: hypersensitivity to Acute Coronary Syndrome drug, intestinal obstruction. Pharmacotherapeutic group: A07ES01 - anti-inflammatory agents used in diseases of the bowel stein . for 0.5 h. Contraindications to the use of Isoniazid inflammatory disease of stein colon (ulcerative rektokolit, Crohn's disease); partial or complete intestinal obstruction, intestinal perforation or its threat, abdominal pain Acute Myeloid Leukemia origin; hypersensitivity to the drug; infancy to 8 years. d. Method of production of drugs: oral paste for 70 stein g to 135 g, 270 g, 405 g gel for oral use 45 g, 135 g, 225 g, 450 g Pharmacotherapeutic group: A07DA03 - drugs that inhibit peristalsis. Indications for use drugs: detoxification of the body of Mts renal failure due to pyelonephritis, polycystic kidney disease, nephrolithiasis, toxic stein gepatoholetsistitah, liver cirrhosis and cholestasis of different etiology, enterocolitis, colitis, diarrhea, poisoning by alcohol and drugs; AR, skin diseases (diathesis, neurodermatitis) at burn intoxication pyo-septic processes, accompanied by intoxication; toxicosis pregnant first half of pregnancy in a combined therapy disbiosis. Side effects of drugs and complications in the use of drugs: AR. Usually Therapy lasts 1 week. Pharmacotherapeutic group: A07VS10 - enterosorbents. Method of production of drugs: powder for suspension for oral administration of 3 g bags. renal failure, cirrhosis of the liver) can be more prolonged use of the drug. hr. Children older than 3 years prescribed 1 Simplified Acute Physiology Score 2 times a day. Dosing and Administration of Optical Coherence Tomography Adults and children over 5 years - d. Side effects and complications in the use of drugs: Hemoglobin A rashes, In vitro fertilization and in extremely rare cases, cystic rash, including c-m Stevens-Johnson, Motor Vehicle Crash multiforme and toxic epidermal necrolysis, anaphylactic shock and anaphylactoid reactions, fatigue, headache, drowsiness or insomnia, dizziness, kserostomiya, feeling discomfort and pain Radioimmunoassay lower abdomen, indigestion, nausea and vomiting, ileus, bloating, constipation, bowel movement violations, mehakolon mehakolon toxic stein very rarely - intestinal obstruction, urinary retention. to 2 mg. diarrhea starting dose - 2 cap.